Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONCORDE: Correlation Between Tissue and Plasmatic EGFR in NSCLC
NCT03265496Terminated
- Sponsor
- Centre Oscar Lambret
- Start
- Jul 2016
- Primary completion
- Apr 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial in non-small cell lung cancer (NSCLC), sponsored by Centre Oscar Lambret. Primary endpoint: Correlation between EGFR mutational status determined after tumor biopsy and EGFR mutational status analyzed after liquid biopsy by NGS. Started Jul 2016; status: terminated.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03265496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03265496.